5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | NEUTRAL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.98▼ | 2.99▼ | 3.00▼ | 3.03▼ | 3.01▼ |
MA10 | 2.99▼ | 3.01▼ | 3.06▼ | 3.06▼ | 2.42▲ |
MA20 | 2.99▼ | 3.07▼ | 3.08▼ | 3.00▼ | 2.03▲ |
MA50 | 3.00▼ | 3.07▼ | 3.05▼ | 2.30▲ | 1.46▲ |
MA100 | 3.06▼ | 3.04▼ | 3.11▼ | 1.89▲ | 1.40▲ |
MA200 | 3.09▼ | 3.06▼ | 2.66▲ | 1.44▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▲ | -0.014▼ | -0.020▼ | -0.044▼ | 0.128▲ |
RSI | 45.416▼ | 36.718▼ | 37.910▼ | 54.602▲ | 74.984▲ |
STOCH | 43.750 | 21.894 | 14.214▼ | 33.558 | 61.618 |
WILL %R | -50.000 | -81.818▼ | -90.909▼ | -67.755 | -37.220 |
CCI | -113.596▼ | -93.557 | -114.124▼ | -56.203 | 98.211 |
MA | $TMC Price Crossed Below MA(7) | Set Alert |
Wednesday, May 14, 2025 03:51 AM
Affimed (Nasdaq: AFMD) is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer by actualizing the untapped potential of the innate immune ...
|
Tuesday, May 13, 2025 01:13 PM
IQSTEL's capital markets journey began with $13.8 million in revenue in 2018. Since then, the company has grown steadily—demonstrating consistent execution, transparency, and scalable performance—with ...
|
Tuesday, May 13, 2025 11:16 AM
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/05/25 | 3.19 | 3.22 | 2.93 | 2.97 | 5,817,375 |
12/05/25 | 3.17 | 3.39 | 3.105 | 3.14 | 9,258,614 |
09/05/25 | 3.03 | 3.13 | 2.98 | 3.11 | 4,122,261 |
08/05/25 | 2.975 | 3.07 | 2.86 | 3.04 | 3,992,129 |
07/05/25 | 3.03 | 3.05 | 2.8114 | 2.91 | 6,236,988 |
06/05/25 | 3.06 | 3.30 | 3.00 | 3.09 | 7,052,955 |
05/05/25 | 3.035 | 3.12 | 2.94 | 3.12 | 5,554,109 |
02/05/25 | 3.15 | 3.34 | 2.955 | 2.98 | 8,550,251 |
01/05/25 | 3.08 | 3.14 | 2.915 | 3.10 | 6,110,073 |
30/04/25 | 3.125 | 3.14 | 2.92 | 3.14 | 6,421,673 |
|
|
||||
|
|
||||
|
|